β2-microglobulin: biomarker evidence

β2-microglobulin appears in 1 entry of the OSMF biomarker atlas, covering Long COVID. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Long COVID

Where β2-microglobulin is reported

Also listed as: MHC class I component

ConditionDirectionCompared againstAssociated symptomsSource
Long COVID↑ elevatedhealthy controlsImmune activationKallaste et al. 2025

Frequently asked questions

In which conditions is β2-microglobulin altered?

In the OSMF atlas β2-microglobulin is reported in Long COVID. It is elevated in 1 across 1 entries.

What is the LOINC code for β2-microglobulin?

Entries in this atlas use LOINC 1952-1. LOINC codes identify the laboratory observation so results can be compared across systems.

Is one abnormal β2-microglobulin result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). β2-microglobulin across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/beta2-microglobulin.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.